Chopra Daveen 4
4 · Edwards Lifesciences Corp · Filed May 9, 2025
Insider Transaction Report
Form 4
Chopra Daveen
CVP, TMTT
Transactions
- Tax Payment
Common Stock
2025-05-07$74.92/sh−627$46,975→ 26,376 total - Award
Common Stock
2025-05-08+9,200→ 35,576 total - Award
Employee Stock Option (Right to Acquire)
2025-05-08+47,000→ 47,000 totalExercise: $74.63From: 2026-05-08Exp: 2032-05-07→ Common Stock (47,000 underlying) - Award
Performance Rights
2025-05-08+9,200→ 9,200 totalFrom: 2028-05-08→ Common Stock (9,200 underlying)
Footnotes (3)
- [F1]These restricted stock units were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
- [F2]These options were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
- [F3]Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards.